Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells

Hypertension

Volumn 50, Issue 6, 2007, Pages 1093-1098

  Sampaio, Walkyria O ^a   De Castro, Carlos Henrique ^a,b   Santos, Robson A S ^a   Schiffrin, Ernesto L ^c   Touyz, Rhian M ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Ang II signaling; Ang (1 7); ERK1 2; Human endothelial cells; NO; Src

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; LUCIGENIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE PHOSPHATASE SHP 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ANGIOTENSIN I; ANGIOTENSIN II; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; NADPH OXIDASE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 36448975192     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.106.084848     Document Type: Article

References (38)

1. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
2. Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cell - implications in cardiovascular disease. Braz J Med Biol Res. 2004;37:1263-1273.
3. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin L, Touyz RM. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007;49:185-192.
4. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox. Role in superoxide generation by angiotensin II in human vascular smooth cells. Arterioscler Thromb Vasc Biol. 2003;23:981-987.
5. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol. 2003;30:860-866.
6. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153-183.
7. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 Mitogenic-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular muscle cell hypertrophy. J Biol Chem. 1998;270:15022-15029.
8. Schmitz U, Ishida T, Ishida M, Surapisitchat J, Hasham M. I, Pelech S, Berck BC. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells. Role in activation of JNK. Circ Res. 1998;82:1272-1278.
9. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 1998;92:441-450.
10. Doan T, Farmer P, Cooney T, Ali SM. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells. Cell Signal. 2004;16:301-311.
11. Tang H, Zhao ZJ, Landon EJ, Inagami T. Regulation of calcium-sensitive tyrosine kinase Pky2 by angiotensin II in endothelial cells. Role of Yes tyrosine kinase and tyrosine phosphatase SHP-2. J Biol Chem. 2000;275:8389-8396.
12. Zhang SQ, Tsiaras WG, Araki T, Wen G, Minichiello L, Klein R, Neel BG. Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2. Mol Cell Biol. 2002;22:4062-4072.
13. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003;100:8258-8263.
14. Heitsch H, Brovkovych S, Malinski T, Wiemer G. Angiotensin-(1-7)- stimulated nitric oxide and superoxide release from endothelial cells. Hypertension. 2001;37:72-76.
15. Rajendran S, Chirkov YY, Campbell DJ. Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside. J Cardiovasc Pharmacol. 2005;46:459-463.
16. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27:523-528.
17. Pörsti I, Bara AT, Busse R, Hecker M. Release of oxide nitric by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
18. Fernandes L, Fortes ZB, Nigro D, Tostes RCA, Santos RAS, Carvalho MHC. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studies in vivo. Hypertension. 2001;37:703-709.
19. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradikinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29:394-400.
20. Zhu Z, Zhong J, Zhu S, Liu D, Van Der Giet M, Tepel M. Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction. J Cardiovasc Pharmacol. 2002;40:693-700.
21. Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension. 2003;42:574-579.
22. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol. 2005;289:H1560-H1566.
23. Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM, Gembardt F, Kellett E, Martini L, Vanderheyden P, Schultheiss HP, Walther T. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation. 2005;111:1806-1813.
24. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension. 2005;46:937-942.
25. Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 2006;69:2212-2218.
26. Diep QN, Intengan HD, Schiffrin EL. Endothelin-1 attenuates omega-3 fatty acid-induced apoptosis by inhibition of caspase 3. Hypertension. 2000;35:287-291.
27. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors. 2003;17:287-296.
28. Viedt C, Fei J, Krieger-Brauer HI, Brandes RP, Teupser D, Kamimura M, Katus HA, Kreuzer J. Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells. J Mol Med. 2004;82:31-38.
29. He Y, Yao G, Savoia C, Touyz RM. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res. 2005;96:207-215.
30. Meng W, Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke. 1993;24:2041-2045.
31. Tran Y, Forster C. Angiotensin-(1-7) and the rat aorta: modulation by endothelium. J Cardiovasc Pharmacol. 1997;30:676-682.
32. Almeida AP, Frabregas BC, Madureira MM, Santos RJ, Campagnole-Santos MJ, Santos RA. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Braz J Med Biol Res. 2000;33:709-713.
33. Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension. 2002;39:799-802.
34. Fernandes L, Fortes ZB, Casarini DE, Nigro D, Tostes RC, Santos RA, De Carvalho MH. Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR. Regul Pept. 2005;127:183-189.
35. Roks AMJ, Van Geel PP, Pinto YM, Buikema H, Henning RH, De Zeeuw D, Van Gilst WH. Angiotensin-(1-7) is a modulator of the human renin angiotensin system. Hypertension. 1999;34:296-301.
36. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell. 2004;13:341-355.
37. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell. 2004;13:341-355.
38. Touyz RM, Wu XH, He G, Salomon S, Schiffrin EL. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 2002;39:479-485.